NATIONAL HEALTHCARE CORP (NHC) Fundamental Analysis & Valuation

NYSEARCA:NHC • US6359061008

Current stock price

164.595 USD
+3.16 (+1.95%)
Last:

This NHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NHC Profitability Analysis

1.1 Basic Checks

  • NHC had positive earnings in the past year.
  • In the past year NHC had a positive cash flow from operations.
  • NHC had positive earnings in each of the past 5 years.
  • NHC had a positive operating cash flow in each of the past 5 years.
NHC Yearly Net Income VS EBIT VS OCF VS FCFNHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.86%, NHC belongs to the top of the industry, outperforming 89.11% of the companies in the same industry.
  • The Return On Equity of NHC (11.23%) is better than 75.25% of its industry peers.
  • The Return On Invested Capital of NHC (7.58%) is better than 71.29% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NHC is below the industry average of 8.94%.
  • The 3 year average ROIC (5.59%) for NHC is below the current ROIC(7.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.86%
ROE 11.23%
ROIC 7.58%
ROA(3y)6.55%
ROA(5y)6.26%
ROE(3y)9.66%
ROE(5y)9.38%
ROIC(3y)5.59%
ROIC(5y)4.83%
NHC Yearly ROA, ROE, ROICNHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • NHC has a Profit Margin of 7.91%. This is amongst the best in the industry. NHC outperforms 88.12% of its industry peers.
  • NHC's Profit Margin has improved in the last couple of years.
  • NHC has a Operating Margin of 8.46%. This is in the better half of the industry: NHC outperforms 75.25% of its industry peers.
  • NHC's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 39.31%, NHC is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
  • NHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.46%
PM (TTM) 7.91%
GM 39.31%
OM growth 3Y47.3%
OM growth 5Y-2.21%
PM growth 3Y56.39%
PM growth 5Y14.19%
GM growth 3Y2.23%
GM growth 5Y-1.42%
NHC Yearly Profit, Operating, Gross MarginsNHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NHC is destroying value.
  • The number of shares outstanding for NHC has been increased compared to 1 year ago.
  • The number of shares outstanding for NHC has been increased compared to 5 years ago.
  • The debt/assets ratio for NHC has been reduced compared to a year ago.
NHC Yearly Shares OutstandingNHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
NHC Yearly Total Debt VS Total AssetsNHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 5.49 indicates that NHC is not in any danger for bankruptcy at the moment.
  • NHC has a better Altman-Z score (5.49) than 88.12% of its industry peers.
  • The Debt to FCF ratio of NHC is 0.27, which is an excellent value as it means it would take NHC, only 0.27 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NHC (0.27) is better than 92.08% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that NHC is not too dependend on debt financing.
  • NHC has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. NHC outperforms 82.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Altman-Z 5.49
ROIC/WACC0.86
WACC8.82%
NHC Yearly LT Debt VS Equity VS FCFNHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.82 indicates that NHC should not have too much problems paying its short term obligations.
  • The Current ratio of NHC (1.82) is better than 74.26% of its industry peers.
  • NHC has a Quick Ratio of 1.79. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
  • NHC has a Quick ratio of 1.79. This is in the better half of the industry: NHC outperforms 75.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.79
NHC Yearly Current Assets VS Current LiabilitesNHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NHC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.38% over the past year.
  • NHC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.00% yearly.
  • The Revenue has grown by 16.09% in the past year. This is quite good.
  • Measured over the past years, NHC shows a quite strong growth in Revenue. The Revenue has been growing by 8.10% on average per year.
EPS 1Y (TTM)17.38%
EPS 3Y74.12%
EPS 5Y23%
EPS Q2Q%306.54%
Revenue 1Y (TTM)16.09%
Revenue growth 3Y11.81%
Revenue growth 5Y8.1%
Sales Q2Q%4.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHC Yearly Revenue VS EstimatesNHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

Find the best growth stocksShow best growing peers

3

4. NHC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 21.46, the valuation of NHC can be described as rather expensive.
  • 66.34% of the companies in the same industry are more expensive than NHC, based on the Price/Earnings ratio.
  • NHC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.46
Fwd PE N/A
NHC Price Earnings VS Forward Price EarningsNHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NHC is valued a bit cheaper than 63.37% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, NHC is valued a bit cheaper than the industry average as 69.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.21
EV/EBITDA 12.29
NHC Per share dataNHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The decent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.93
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. NHC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.64%, NHC has a reasonable but not impressive dividend return.
  • NHC's Dividend Yield is rather good when compared to the industry average which is at 0.50. NHC pays more dividend than 89.11% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, NHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • The dividend of NHC has a limited annual growth rate of 3.74%.
  • NHC has paid a dividend for at least 10 years, which is a reliable track record.
  • NHC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.74%
Div Incr Years11
Div Non Decr Years11
NHC Yearly Dividends per shareNHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 32.25% of the earnings are spent on dividend by NHC. This is a low number and sustainable payout ratio.
  • NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP32.25%
EPS Next 2YN/A
EPS Next 3YN/A
NHC Yearly Income VS Free CF VS DividendNHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M
NHC Dividend Payout.NHC Dividend Payout, showing the Payout Ratio.NHC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NHC Fundamentals: All Metrics, Ratios and Statistics

NATIONAL HEALTHCARE CORP

NYSEARCA:NHC (3/16/2026, 3:58:47 PM)

164.595

+3.16 (+1.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners64.91%
Inst Owner Change3.98%
Ins Owners7.03%
Ins Owner Change0.72%
Market Cap2.56B
Revenue(TTM)1.52B
Net Income(TTM)120.02M
Analysts60
Price TargetN/A
Short Float %3.79%
Short Ratio6.22
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend2.5
Dividend Growth(5Y)3.74%
DP32.25%
Div Incr Years11
Div Non Decr Years11
Ex-Date03-31
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.46
Fwd PE N/A
P/S 1.69
P/FCF 17.21
P/OCF 13.82
P/B 2.39
P/tB 2.91
EV/EBITDA 12.29
EPS(TTM)7.67
EY4.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.56
FCFY5.81%
OCF(TTM)11.91
OCFY7.24%
SpS97.67
BVpS68.78
TBVpS56.53
PEG (NY)N/A
PEG (5Y)0.93
Graham Number108.95
Profitability
Industry RankSector Rank
ROA 7.86%
ROE 11.23%
ROCE 10.08%
ROIC 7.58%
ROICexc 9.49%
ROICexgc 11.67%
OM 8.46%
PM (TTM) 7.91%
GM 39.31%
FCFM 9.79%
ROA(3y)6.55%
ROA(5y)6.26%
ROE(3y)9.66%
ROE(5y)9.38%
ROIC(3y)5.59%
ROIC(5y)4.83%
ROICexc(3y)6.91%
ROICexc(5y)6.01%
ROICexgc(3y)8.5%
ROICexgc(5y)7.43%
ROCE(3y)7.43%
ROCE(5y)6.42%
ROICexgc growth 3Y57.26%
ROICexgc growth 5Y3.29%
ROICexc growth 3Y57.83%
ROICexc growth 5Y-0.34%
OM growth 3Y47.3%
OM growth 5Y-2.21%
PM growth 3Y56.39%
PM growth 5Y14.19%
GM growth 3Y2.23%
GM growth 5Y-1.42%
F-Score9
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Debt/EBITDA 0.19
Cap/Depr 81.14%
Cap/Sales 2.4%
Interest Coverage 18.26
Cash Conversion 106.81%
Profit Quality 123.85%
Current Ratio 1.82
Quick Ratio 1.79
Altman-Z 5.49
F-Score9
WACC8.82%
ROIC/WACC0.86
Cap/Depr(3y)71.08%
Cap/Depr(5y)76.94%
Cap/Sales(3y)2.32%
Cap/Sales(5y)2.68%
Profit Quality(3y)108.92%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.38%
EPS 3Y74.12%
EPS 5Y23%
EPS Q2Q%306.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.09%
Revenue growth 3Y11.81%
Revenue growth 5Y8.1%
Sales Q2Q%4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.78%
EBIT growth 3Y64.7%
EBIT growth 5Y5.71%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.48%
FCF growth 3YN/A
FCF growth 5Y-3.9%
OCF growth 1Y72.48%
OCF growth 3Y176.64%
OCF growth 5Y-1.86%

NATIONAL HEALTHCARE CORP / NHC Fundamental Analysis FAQ

What is the fundamental rating for NHC stock?

ChartMill assigns a fundamental rating of 6 / 10 to NHC.


Can you provide the valuation status for NATIONAL HEALTHCARE CORP?

ChartMill assigns a valuation rating of 3 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Overvalued.


How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?

NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 7 / 10.


How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?

The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 32.25%.